Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Leukemia. 2019 Jun 17;33(8):1835–1850. doi: 10.1038/s41375-019-0512-y

Figure 2. Comparison of variants in two studies of patients at BC.

Figure 2.

(a) Mutant genes at BC reported in the study of Grossman et al. [47]. (b) Mutant genes at BC reported in the study of Branford et al. [22]. The most frequently mutated genes were common to both studies: RUNX1, ASXL1 and IKZF1 exon deletions. These were detected in >50% of patients in both studies. Genes mutated in both studies are indicated by matching colors. Light grey shading indicates genes that were sequenced in both studies but were only detected in one of the studies. Dark grey shading indicates the genes that were only sequenced in one study.